Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study

Bibliographic Details
Title: Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study
Authors: Riju Ray, Beth Hahn, Richard H. Stanford, John White, Breanna Essoi, Alyssa Goolsby Hunter
Source: Pulmonary Therapy, Vol 5, Iss 2, Pp 191-200 (2019)
Publisher Information: Adis, Springer Healthcare, 2019.
Publication Year: 2019
Collection: LCC:Diseases of the respiratory system
Subject Terms: Bronchodilator agents, COPD, Exacerbation, GOLD, LAMA monotherapy, Patient-reported outcome measures, Diseases of the respiratory system, RC705-779
More Details: Abstract Introduction To address the burden of chronic obstructive pulmonary disease (COPD), the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends treatment according to classification of patients by symptom severity and exacerbation risk. This post hoc analysis of a previously reported claims-linked, cross-sectional survey [study 205862 (HO-16-16642)] classified patients with COPD receiving long-acting muscarinic antagonist (LAMA) monotherapy based on the GOLD 2017 categories. Methods Eligible patients who were ≥ 40 years of age, with ≥ 2 claims with International Classification of Diseases-10th Revision-Clinical Modification COPD diagnosis codes J40–J44 ≥ 30 days apart during the 12-month baseline period, and ≥ 2 claims for LAMA monotherapy in the 6 months prior to identification, were identified using claims data from the Optum Research Database. Patients completed a survey assessing modified Medical Research Council (mMRC) Dyspnea Scale and COPD Assessment Test (CAT) scores and demographics; clinical characteristics were assessed from claims and survey data, while exacerbation history was assessed from claims data. GOLD symptom severity classifications were low (groups A and C) for patients with low scores on both the CAT and mMRC scales (scores of
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2364-1754
2364-1746
Relation: http://link.springer.com/article/10.1007/s41030-019-00099-0; https://doaj.org/toc/2364-1754; https://doaj.org/toc/2364-1746
DOI: 10.1007/s41030-019-00099-0
Access URL: https://doaj.org/article/d14f80eacb7548ceabf50b96e4f0e32f
Accession Number: edsdoj.14f80eacb7548ceabf50b96e4f0e32f
Database: Directory of Open Access Journals
More Details
ISSN:23641754
23641746
DOI:10.1007/s41030-019-00099-0
Published in:Pulmonary Therapy
Language:English